L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
The newly developed Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) has consistently been shown to be prognostically significant in endometrial carcinomas (EC). Recently, we and others have demonstrated L1 cell-adhesion molecule (L1CAM) to be a significant indicator of high-risk...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
27 July 2018
|
| In: |
British journal of cancer
Year: 2018, Jahrgang: 119, Heft: 4, Pages: 480-486 |
| ISSN: | 1532-1827 |
| DOI: | 10.1038/s41416-018-0187-6 |
| Online-Zugang: | Resolving-System, Volltext: https://doi.org/10.1038/s41416-018-0187-6 Verlag: https://www.nature.com/articles/s41416-018-0187-6 
|
| Verfasserangaben: | Felix KF Kommoss, Anthony N. Karnezis, Friedrich Kommoss, Aline Talhouk, Florin-Andrei Taran, Annette Staebler, C. Blake Gilks, David G. Huntsman, Bernhard Krämer, Sara Y. Brucker, Jessica N. McAlpine and Stefan Kommoss |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1685689396 | ||
| 003 | DE-627 | ||
| 005 | 20230427132816.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191216s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41416-018-0187-6 |2 doi | |
| 035 | |a (DE-627)1685689396 | ||
| 035 | |a (DE-599)KXP1685689396 | ||
| 035 | |a (OCoLC)1341282231 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kommoss, Felix |d 1991- |e VerfasserIn |0 (DE-588)1171010427 |0 (DE-627)1040361315 |0 (DE-576)512915164 |4 aut | |
| 245 | 1 | 0 | |a L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile |c Felix KF Kommoss, Anthony N. Karnezis, Friedrich Kommoss, Aline Talhouk, Florin-Andrei Taran, Annette Staebler, C. Blake Gilks, David G. Huntsman, Bernhard Krämer, Sara Y. Brucker, Jessica N. McAlpine and Stefan Kommoss |
| 264 | 1 | |c 27 July 2018 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.12.2019 | ||
| 520 | |a The newly developed Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) has consistently been shown to be prognostically significant in endometrial carcinomas (EC). Recently, we and others have demonstrated L1 cell-adhesion molecule (L1CAM) to be a significant indicator of high-risk disease in EC. In the current study, it was our aim to determine the prognostic significance of aberrant L1CAM expression in ProMisE subgroups in a large, single centre, population-based EC cohort. | ||
| 773 | 0 | 8 | |i Enthalten in |t British journal of cancer |d Edinburgh : Nature Publ. Group, 1947 |g 119(2018), 4, Seite 480-486 |h Online-Ressource |w (DE-627)320420094 |w (DE-600)2002452-6 |w (DE-576)103746854 |x 1532-1827 |7 nnas |a L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile |
| 773 | 1 | 8 | |g volume:119 |g year:2018 |g number:4 |g pages:480-486 |g extent:7 |a L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41416-018-0187-6 |x Resolving-System |x Verlag |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41416-018-0187-6 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191216 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1171010427 |a Kommoss, Felix |m 1171010427:Kommoss, Felix |d 910000 |d 912000 |e 910000PK1171010427 |e 912000PK1171010427 |k 0/910000/ |k 1/910000/912000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1685689396 |e 3565688580 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"27 July 2018"}],"relHost":[{"title":[{"title":"British journal of cancer","subtitle":"BJC","title_sort":"British journal of cancer"}],"note":["Gesehen am 27.10.25"],"type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2002452-6"],"issn":["1532-1827"],"eki":["320420094"]},"language":["eng"],"titleAlt":[{"title":"BJC"}],"recId":"320420094","part":{"year":"2018","text":"119(2018), 4, Seite 480-486","extent":"7","issue":"4","volume":"119","pages":"480-486"},"pubHistory":["Volume 1, issue 1 (1 March 1947)-"],"disp":"L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profileBritish journal of cancer","origin":[{"dateIssuedKey":"1947","publisherPlace":"Edinburgh ; Edinburgh","dateIssuedDisp":"1947-","publisher":"Nature Publ. Group ; Churchill Livingstone"}]}],"name":{"displayForm":["Felix KF Kommoss, Anthony N. Karnezis, Friedrich Kommoss, Aline Talhouk, Florin-Andrei Taran, Annette Staebler, C. Blake Gilks, David G. Huntsman, Bernhard Krämer, Sara Y. Brucker, Jessica N. McAlpine and Stefan Kommoss"]},"physDesc":[{"extent":"7 S."}],"language":["eng"],"id":{"eki":["1685689396"],"doi":["10.1038/s41416-018-0187-6"]},"recId":"1685689396","title":[{"title":"L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile","title_sort":"L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile"}],"person":[{"family":"Kommoss","display":"Kommoss, Felix","roleDisplay":"VerfasserIn","role":"aut","given":"Felix"}],"note":["Gesehen am 16.12.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a KOMMOSSFELL1CAMFURTH2720 | ||